Found: 17
Select item for more details and to access through your institution.
Host Restriction Factors Modulating HIV Latency and Replication in Macrophages.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 6, p. 3021, doi. 10.3390/ijms23063021
- By:
- Publication type:
- Article
Centriolar distal appendages activate the centrosome‐PIDDosome‐p53 signalling axis via ANKRD26.
- Published in:
- EMBO Journal, 2021, v. 40, n. 4, p. 1, doi. 10.15252/embj.2020104844
- By:
- Publication type:
- Article
Quantification of Reverse Transcriptase Activity by Real-Time PCR as a Fast and Accurate Method for Titration of HIV, Lenti- and Retroviral Vectors.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0050859
- By:
- Publication type:
- Article
The Carboxyl-Terminus of Human Immunodeficiency Virus Type 2 Circulating Recombinant form 01_AB Capsid Protein Affects Sensitivity to Human TRIM5α.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047757
- By:
- Publication type:
- Article
TRIM5 is an innate immune sensor for the retrovirus capsid lattice.
- Published in:
- Nature, 2011, v. 472, n. 7343, p. 361, doi. 10.1038/nature09976
- By:
- Publication type:
- Article
A Conserved Acidic Residue in the C-Terminal Flexible Loop of HIV-1 Nef Contributes to the Activity of SERINC5 and CD4 Downregulation.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 3, p. 652, doi. 10.3390/v15030652
- By:
- Publication type:
- Article
Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 9, p. 1745, doi. 10.3390/v13091745
- By:
- Publication type:
- Article
Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 7, p. 1279, doi. 10.3390/v13071279
- By:
- Publication type:
- Article
Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIV<sub>MAC</sub>/SIV<sub>SM</sub>/HIV-2 Lineage Prior to Integration.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 7, p. 1, doi. 10.1371/journal.ppat.1005050
- By:
- Publication type:
- Article
Nef Decreases HIV-1 Sensitivity to Neutralizing Antibodies that Target the Membrane-proximal External Region of TMgp41.
- Published in:
- PLoS Pathogens, 2011, v. 7, n. 12, p. 1, doi. 10.1371/journal.ppat.1002442
- By:
- Publication type:
- Article
Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-76375-w
- By:
- Publication type:
- Article
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.
- Published in:
- Nature, 2015, v. 526, n. 7572, p. 212, doi. 10.1038/nature15399
- By:
- Publication type:
- Article
The activity of Nef on HIV-1 infectivity.
- Published in:
- Frontiers in Microbiology, 2014, v. 5, p. 1, doi. 10.3389/fmicb.2014.00232
- By:
- Publication type:
- Article
Identifying features of the lentiviral genome crucial for the establishment of latency.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
Understanding the nature of the Nef requirement for HIV-1 infectivity.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
Functional analyses of glycosylated gag molecules derived from different gammaretroviruses.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
Lv4, an activity that restricts nuclear entry of SIV<sub>MAC</sub>/SIV<sub>SM</sub> in human blood cells.
- Published in:
- 2013
- By:
- Publication type:
- Abstract